Allogene Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PFIZER INC | 05/12/2026 | 22.03 M | $49.79 M | 0.00% | 9.99% |
| BLACKROCK, INC. | 05/13/2026 | 19.09 M | $46.58 M | 8.01% | 8.65% |
| TPG GP A, LLC | 05/15/2026 | 18.72 M | $45.67 M | 0.00% | 8.48% |
| STATE STREET CORP | 05/15/2026 | 8.66 M | $21.13 M | 213.62% | 3.93% |
| PRIMECAP MANAGEMENT CO/CA/ | 05/11/2026 | 8.38 M | $20.45 M | 2.95% | 3.80% |
| 05/15/2026 | 6.92 M | $16.89 M | 100.00% | 3.14% | |
| CITADEL ADVISORS LLC | 05/15/2026 | 6.79 M | $16.58 M | -43.91% | 3.08% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 5.38 M | $13.13 M | 67.67% | 2.44% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 5.38 M | $13.12 M | 57.02% | 2.44% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 4.12 M | $10.07 M | 4.86% | 1.87% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 3.80 M | $9.26 M | -1.86% | 1.72% |
| WOODLINE PARTNERS LP | 05/15/2026 | 3.50 M | $8.54 M | 0.02% | 1.59% |
| PATIENT SQUARE CAPITAL LP | 05/15/2026 | 3.45 M | $8.42 M | -30.50% | 1.56% |
| MARSHALL WACE, LLP | 05/15/2026 | 3.45 M | $8.41 M | 1,107.44% | 1.56% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 3.32 M | $8.11 M | 80.42% | 1.51% |
| CANDRIAM S.C.A. | 04/30/2026 | 3.00 M | $7.31 M | 30.00% | 1.36% |
| WILDCAT CAPITAL MANAGEMENT, LLC | 05/01/2026 | 2.92 M | $7.13 M | 0.00% | 1.32% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 2.77 M | $6.75 M | 20.83% | 1.25% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 2.76 M | $6.74 M | 115.42% | 1.25% |
| BOXER CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.73 M | $6.65 M | 100.00% | 1.24% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 2.48 M | $6.06 M | 73.85% | 1.13% |
| NUVEEN, LLC | 04/30/2026 | 2.32 M | $5.65 M | 751.11% | 1.05% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 2.24 M | $5.47 M | 100.00% | 1.02% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 2.14 M | $5.22 M | -2.18% | 0.97% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 2.13 M | $5.21 M | 111.89% | 0.97% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2026 | 2.01 M | $4.91 M | 100.00% | 0.91% |
| 05/08/2026 | 1.69 M | $4.13 M | 100.00% | 0.77% | |
| UBS GROUP AG | 05/05/2026 | 1.60 M | $3.91 M | 15.44% | 0.73% |
| FMR LLC | 05/15/2026 | 1.59 M | $3.88 M | 9.96% | 0.72% |
| ABRDN PLC | 04/29/2026 | 1.46 M | $3.57 M | -29.91% | 0.66% |
| JPMORGAN CHASE & CO | 05/13/2026 | 1.43 M | $3.18 M | 46.53% | 0.65% |
| 05/15/2026 | 1.43 M | $3.49 M | 100.00% | 0.65% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 1.40 M | $3.41 M | 3.00% | 0.63% |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2026 | 1.37 M | $3.34 M | -0.72% | 0.62% |
| NORTHERN TRUST CORP | 05/14/2026 | 1.29 M | $3.14 M | 7.28% | 0.58% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 1.20 M | $2.93 M | 25.46% | 0.54% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 1.18 M | $2.89 M | 100.00% | 0.54% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 1.09 M | $2.66 M | 100.00% | 0.49% |
| MORGAN STANLEY | 05/15/2026 | 998.85 K | $2.44 M | 42.06% | 0.45% |
| RAIFFEISEN BANK INTERNATIONAL AG | 04/24/2026 | 700.00 K | $1.55 M | -22.22% | 0.32% |
| INVESCO LTD. | 05/12/2026 | 684.52 K | $1.67 M | 12.25% | 0.31% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2026 | 654.18 K | $1.60 M | 34.99% | 0.30% |
| TD ASSET MANAGEMENT INC | 05/11/2026 | 652.48 K | $1.59 M | 57.58% | 0.30% |
| VOLEON CAPITAL MANAGEMENT LP | 05/15/2026 | 640.60 K | $1.56 M | 100.00% | 0.29% |
| IEQ CAPITAL, LLC | 05/15/2026 | 614.19 K | $1.50 M | 41.11% | 0.28% |
| JANE STREET GROUP, LLC | 05/12/2026 | 505.27 K | $1.23 M | -76.61% | 0.23% |
| ALGERT GLOBAL LLC | 05/14/2026 | 463.98 K | $1.13 M | 136.24% | 0.21% |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 05/12/2026 | 428.70 K | $1.05 M | 208.64% | 0.19% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 395.19 K | $964.26 K | -2.63% | 0.18% |
| CREATIVE PLANNING | 05/12/2026 | 364.81 K | $890.13 K | 33.44% | 0.17% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Allogene Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 250 institutional investors and hedge funds held shares of Allogene Therapeutics Inc. The most heavily invested institutionals were:
PFIZER INC: 22.03 M
BlackRock, Inc.: 19.09 M
TPG GP A, LLC: 18.72 M
STATE STREET CORP: 8.66 M
PRIMECAP MANAGEMENT CO/CA/: 8.38 M
CITADEL ADVISORS LLC: 6.79 M
83.47% of Allogene Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 227.33 M shares in the last 24 months. This purchase volume represents approximately $568.32 M in transactions.